New Drug to Boost Women’s Sex Drive Approved in US
U.S. women will soon have another drug option designed to boost low sex drive: a shot they can give themselves in the thigh or abdomen that raises sexual interest for several hours.
Read moreFDA
FDA Goes After Vaping ‘Influencers’ on Social Media
The Food and Drug Administration called out vaping companies Friday for violating advertising rules through their social media promotions of flavored nicotine products by paid “influencers.”
Read moreExperts Seek Regulation to Forestall ‘Wild West’ of CBD Usage
Racing to catch up to an already booming industry for CBD products, the Food and Drug Administration met with experts Friday to determine whether the compound celebrated by its users as a miracle salve should face tighter regulation.
Read moreFederal Judge Orders FDA Regulation of E-Cigarettes
A federal judge sided with health advocacy groups in ruling that the Food and Drug Administration must stop electronic cigarette companies from selling their products until they win approval from the agency.
Read moreThe Beef Over What to Call Lab Meat Is Starting to Sizzle
Technology has ushered in a new era for food, prompting lawmakers across the nation to ask: What is meat?
Read moreUS Halts Sales of Pelvic Mesh Tied to Injuries in Women
U.S. health regulators on Tuesday halted sales of a type of surgical mesh used to repair pelvic conditions in women, following years of patients’ reports of injuries and complications from the implants.
Read moreUS Experts: Too Soon to Pull Breast Implants Tied to Cancer
Government medical advisers said Monday it’s too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem.
Read moreFDA Approves First-Ever Drug for Postpartum Depression
Giving hope to the 1 in 9 women who experience postpartum depression, the U.S. Food and Drug Administration approved the first drug to treat PPD.
Read moreSan Francisco Proposes Crackdown on E-Cigs
Citing lax federal regulation, San Francisco officials on Tuesday proposed banning the sale of e-cigarettes not reviewed by the U.S. Food and Drug Administration and stopping e-cigarette companies from doing business on city property.
Read moreHealth Plans Fight to Revive Avandia Suit at 3rd Circuit
Fighting to revive a class action, a lawyer for health plans told the Third Circuit on Wednesday that GlaxoSmithKline fumbled its responsibility to warn about the diabetes drug Avandia’s link to cardiovascular problems.
Read moreFDA Targets Supplements Claiming to Help Alzheimer’s
The U.S. Food and Drug Administration said Monday it is tightening regulations on companies that make nutritional supplements, especially those that make claims about curing or preventing Alzheimer’s disease.
Read moreFDA to Crack Down on Menthol Cigarettes, Flavored Vapes
A top U.S. health official on Thursday pledged to try to ban menthol from regular cigarettes, outlaw flavors in all cigars, and tighten rules regarding the sale of most flavored versions of electronic cigarettes.
Read morePowerful Opioid Pill Gets FDA Approval
Announcing the approval of a tablet alternative to a powerful opioid normally delivered intravenously, the commissioner of the Food and Drug Administration promised Friday that the drug Dsuvia will be very tightly regulated.
Read moreOver-the-Counter Drugs
Keystone Laboratories has repeatedly failed to correct deficiencies cited by the FDA, including adulteration and misbranding of its over-the-counter drugs, the United States claims in a federal complaint.
Read moreFDA Calls E-Cigarette Use a Youth Epidemic
Warning that e-cigarettes use by minors has reached “epidemic proportions,” the FDA imposed fines Wednesday and sent warning letters to 1,300 retailers that sell vaping devices.
Read moreE-Cigarette Regulation Case Kicks Up Smoke in DC Circuit
Casting federal restrictions on e-cigarette advertising and sales as an existential threat, a trade group for the vaping industry urged the D.C. Circuit on Tuesday to block a rule change by the Food and Drug Administration.
Read moreFeds Ordered to Finalize Graphic Cigarette Warnings
A federal judge in Massachusetts ordered the U.S. Food and Drug Administration on Wednesday to stop delaying the implementation of graphic warning labels on cigarette packs.
Read moreCourt Reverses $3M Award Over Antidepressant Label
GlaxoSmithKline cannot be held responsible for failing to warn older adults of the suicide risk attached to its antidepressant drug Paxil because the government refused to allow the drugmaker to add such a warning, the Seventh Circuit ruled.
Read more11th Circuit Hears Supplement Maker’s Fight With Feds
Attorneys for a dietary supplement manufacturer asked the 11th Circuit on Friday to overturn a district court ruling which found that the U.S. government rightfully seized $2.2 million worth of a supplement ingredient.
Read more